Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bioxytran, Inc. stock logo
BIXT
Bioxytran
$0.09
-7.0%
$0.12
$0.06
$0.23
$8.38M1.5584,248 shs34,505 shs
Eledon Pharmaceuticals, Inc. stock logo
ELDN
Eledon Pharmaceuticals
$3.42
-0.9%
$2.98
$2.38
$5.54
$204.80M-0.16322,846 shs325,275 shs
NTN Buzztime, Inc. stock logo
NTN
NTN Buzztime
$1.95
-1.5%
$1.01
$0.94
$7.76
$5.81M0.721.63 million shs15,939 shs
Sonoma Pharmaceuticals, Inc. stock logo
SNOA
Sonoma Pharmaceuticals
$3.61
-8.4%
$3.17
$1.75
$9.00
$5.93M1.33802,351 shs255,884 shs
XTLB
XTL Biopharmaceuticals
$1.51
+33.2%
$3.99
$0.86
$3.05
$8.23M1.0524,161 shsN/A
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bioxytran, Inc. stock logo
BIXT
Bioxytran
0.00%-5.80%-14.29%-47.81%-0.84%
Eledon Pharmaceuticals, Inc. stock logo
ELDN
Eledon Pharmaceuticals
0.00%+13.81%+14.00%+16.33%+40.74%
NTN Buzztime, Inc. stock logo
NTN
NTN Buzztime
-1.52%-2.50%+1,130.28%+919.87%+1.59%
Sonoma Pharmaceuticals, Inc. stock logo
SNOA
Sonoma Pharmaceuticals
0.00%+21.14%+14.24%+57.64%+1,304.12%
XTLB
XTL Biopharmaceuticals
0.00%+7.12%+26.47%+29.74%-31.59%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Bioxytran, Inc. stock logo
BIXT
Bioxytran
0.4771 of 5 stars
0.05.00.00.00.01.70.0
Eledon Pharmaceuticals, Inc. stock logo
ELDN
Eledon Pharmaceuticals
1.5206 of 5 stars
3.51.00.00.01.61.70.0
NTN Buzztime, Inc. stock logo
NTN
NTN Buzztime
N/AN/AN/AN/AN/AN/AN/AN/A
Sonoma Pharmaceuticals, Inc. stock logo
SNOA
Sonoma Pharmaceuticals
0.7322 of 5 stars
0.05.00.00.02.70.00.0
XTLB
XTL Biopharmaceuticals
0.4792 of 5 stars
0.05.00.00.00.01.70.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bioxytran, Inc. stock logo
BIXT
Bioxytran
0.00
N/AN/AN/A
Eledon Pharmaceuticals, Inc. stock logo
ELDN
Eledon Pharmaceuticals
3.00
Buy$9.00163.16% Upside
NTN Buzztime, Inc. stock logo
NTN
NTN Buzztime
0.00
N/AN/AN/A
Sonoma Pharmaceuticals, Inc. stock logo
SNOA
Sonoma Pharmaceuticals
0.00
N/AN/AN/A
XTLB
XTL Biopharmaceuticals
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest NTN, XTLB, BIXT, SNOA, and ELDN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/18/2025
Eledon Pharmaceuticals, Inc. stock logo
ELDN
Eledon Pharmaceuticals
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeBuy$9.00
(Data available from 7/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bioxytran, Inc. stock logo
BIXT
Bioxytran
N/AN/AN/AN/A($0.02) per shareN/A
Eledon Pharmaceuticals, Inc. stock logo
ELDN
Eledon Pharmaceuticals
N/AN/AN/AN/A$1.98 per shareN/A
NTN Buzztime, Inc. stock logo
NTN
NTN Buzztime
$19.81M0.29$0.45 per share4.38$1.76 per share1.11
Sonoma Pharmaceuticals, Inc. stock logo
SNOA
Sonoma Pharmaceuticals
$14.29M0.41N/AN/A$2.73 per share1.32
XTLB
XTL Biopharmaceuticals
$450K18.23N/AN/A$1.00 per share1.51
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bioxytran, Inc. stock logo
BIXT
Bioxytran
-$2.37M-$0.03N/AN/AN/AN/A-2,077.16%N/A
Eledon Pharmaceuticals, Inc. stock logo
ELDN
Eledon Pharmaceuticals
-$36.18M-$2.10N/AN/AN/AN/A-79.54%-41.62%8/18/2025 (Estimated)
NTN Buzztime, Inc. stock logo
NTN
NTN Buzztime
-$2.05MN/AN/AN/A-61.42%-162.54%-49.94%N/A
Sonoma Pharmaceuticals, Inc. stock logo
SNOA
Sonoma Pharmaceuticals
-$3.46M-$3.10N/AN/AN/A-24.23%-58.73%-21.05%8/6/2025 (Estimated)
XTLB
XTL Biopharmaceuticals
-$1.03MN/A0.00N/AN/AN/AN/AN/A

Latest NTN, XTLB, BIXT, SNOA, and ELDN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
6/17/2025Q4 2025
Sonoma Pharmaceuticals, Inc. stock logo
SNOA
Sonoma Pharmaceuticals
-$0.73-$0.15+$0.58-$0.48$4.44 million$3.75 million
5/15/2025Q1 2025
Bioxytran, Inc. stock logo
BIXT
Bioxytran
N/A-$0.02N/A-$0.02N/AN/A
5/14/2025Q1 2025
Eledon Pharmaceuticals, Inc. stock logo
ELDN
Eledon Pharmaceuticals
-$0.28-$0.08+$0.20-$0.08N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Bioxytran, Inc. stock logo
BIXT
Bioxytran
N/AN/AN/AN/AN/A
Eledon Pharmaceuticals, Inc. stock logo
ELDN
Eledon Pharmaceuticals
N/AN/AN/AN/AN/A
NTN Buzztime, Inc. stock logo
NTN
NTN Buzztime
N/AN/AN/AN/AN/A
Sonoma Pharmaceuticals, Inc. stock logo
SNOA
Sonoma Pharmaceuticals
N/AN/AN/AN/AN/A
XTLB
XTL Biopharmaceuticals
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bioxytran, Inc. stock logo
BIXT
Bioxytran
N/AN/AN/A
Eledon Pharmaceuticals, Inc. stock logo
ELDN
Eledon Pharmaceuticals
N/A
13.90
13.91
NTN Buzztime, Inc. stock logo
NTN
NTN Buzztime
3.30
0.95
0.95
Sonoma Pharmaceuticals, Inc. stock logo
SNOA
Sonoma Pharmaceuticals
N/A
3.09
2.38
XTLB
XTL Biopharmaceuticals
N/A
0.61
0.61

Institutional Ownership

CompanyInstitutional Ownership
Bioxytran, Inc. stock logo
BIXT
Bioxytran
N/A
Eledon Pharmaceuticals, Inc. stock logo
ELDN
Eledon Pharmaceuticals
56.77%
NTN Buzztime, Inc. stock logo
NTN
NTN Buzztime
6.31%
Sonoma Pharmaceuticals, Inc. stock logo
SNOA
Sonoma Pharmaceuticals
1.95%
XTLB
XTL Biopharmaceuticals
4.40%
CompanyEmployeesShares OutstandingFree FloatOptionable
Bioxytran, Inc. stock logo
BIXT
Bioxytran
288.99 million26.70 millionNot Optionable
Eledon Pharmaceuticals, Inc. stock logo
ELDN
Eledon Pharmaceuticals
1059.88 million52.52 millionOptionable
NTN Buzztime, Inc. stock logo
NTN
NTN Buzztime
192.98 millionN/ANot Optionable
Sonoma Pharmaceuticals, Inc. stock logo
SNOA
Sonoma Pharmaceuticals
1801.64 million1.58 millionNot Optionable
XTLB
XTL Biopharmaceuticals
N/A5.45 million3.87 millionNot Optionable

Recent News About These Companies

XTL Biopharmaceuticals Ltd. (XTLB) - Yahoo Finance
XTL Biopharmaceuticals names Noam Band as CEO
XTL Biopharmaceuticals Appoints Noam Band as CEO
XTL Biopharmaceuticals Ltd (XTLB)
XTL Biopharmaceuticals Ltd XTLB
XTL Biopharmaceuticals acquires AI firm Social Proxy
XTL Biopharmaceuticals Ltd. (XTLB.TA)
XTL Biopharmaceuticals Ltd. ADR
Dow Surges 350 Points; Fed Holds Rates Steady
Crude Oil Surges 2%; Signet Jewelers Shares Spike Higher

New MarketBeat Followers Over Time

Media Sentiment Over Time

Bioxytran stock logo

Bioxytran OTCMKTS:BIXT

$0.09 -0.01 (-7.01%)
As of 07/11/2025 03:49 PM Eastern

Bioxytran, Inc., a clinical stage pharmaceutical company, focuses on the development, manufacture, and commercialization of therapeutic drugs to address hypoxia in humans. The company's lead drug candidate is BXT-25, an oxygen-carrying small molecule consisting of bovine hemoglobin stabilized with a co-polymer for use in the treatment of hypoxic conditions in the brain resulting from stroke, and hypoxic conditions in wounds to prevent necrosis and to promote healing. It is also developing ProLectin-Rx, a polysaccharide derived from pectin that binds to, and blocks the activity of galectin-1, a type of galectin for treatment of mild to moderate cases of Covid-19. The company was founded in 2008 and is headquartered in Needham, Massachusetts.

Eledon Pharmaceuticals stock logo

Eledon Pharmaceuticals NASDAQ:ELDN

$3.42 -0.03 (-0.87%)
Closing price 07/11/2025 04:00 PM Eastern
Extended Trading
$3.42 0.00 (0.00%)
As of 07/11/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Eledon Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. The company uses its immunology expertise in targeting the CD40 Ligand (CD40L, also called CD154) pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis (ALS). The company's lead compound in development is tegoprubart, an IgG1 and anti-CD40L antibody with high affinity for CD40 Ligand, a biological target with therapeutic potential. It has a collaboration agreement with eGenesis, Inc. The company was formerly known as Novus Therapeutics, Inc. and changed its name to Eledon Pharmaceuticals, Inc. in January 2021. Eledon Pharmaceuticals, Inc. is headquartered in Irvine, California.

NTN Buzztime stock logo

NTN Buzztime NYSEAMERICAN:NTN

$1.95 -0.03 (-1.52%)
As of 07/11/2025

NTN Buzztime, Inc., together with its subsidiaries, provides interactive entertainment and technology to bars, restaurants, casinos, and senior living centers in the United States and Canada. Its principal product and service is its tablet platform. The company also leases equipment, including tablets, and cases and charging trays for the tablets to various network subscribers. It also licenses its content to customers to be installed on equipment that they obtain from other parties. The company's interactive entertainment system offers trivia, card, sports, and arcade games. It owns various trademarks, including the Buzztime, Playmaker, Mobile Playmaker, and BEOND Powered. As of June 30, 2020, NTN Buzztime, Inc. served 1,219 venues with its interactive entertainment network. The company was formerly known as NTN Communications, Inc. and changed its name to NTN Buzztime, Inc. in 2005. NTN Buzztime, Inc. was founded in 1982 and is based in Carlsbad, California.

Sonoma Pharmaceuticals stock logo

Sonoma Pharmaceuticals NASDAQ:SNOA

$3.61 -0.33 (-8.38%)
Closing price 07/11/2025 04:00 PM Eastern
Extended Trading
$3.78 +0.17 (+4.57%)
As of 07/11/2025 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for wound care, animal health care, eye care, oral care, and dermatological conditions in the United States, Latin America, Europe, Asia, and internationally. The company offers Regenacyn, a prescription scar gel; Pediacyn, a pediatric dermatology and wound care product for over-the-counter (OTC) use; Epicyn, an Antimicrobial Facial Cleanser; Levicyn, an HOCl based prescription and OTC product to use and relieve skin irritations, lacerations, abrasions, and burns; Celacyn, a scar management gel; and SebuDerm to manage and relieve the burning, itching, erythema, scaling, and pain associated with seborrhea and seborrheic dermatitis. It also provides Gramaderm for the treatment of topical mild to moderate acne; Microcyn, a HOCl-based topical line of products designed to stimulate expedited healing by targeting a wide range of pathogens; Ocucyn eyelid and eyelash cleanser; Microdacyn60 oral care solution for the treatment of mouth and throat infections; and Podiacyn, a foot care product. In addition, the company offers MicrocynAH, an HOCl-based solution designed to relieve common symptoms of hot spots, scratches, skin rashes post-surgical sites, and irritated animal skin for healing; MicrocynVS, a veterinarian-strength animal care product used in vet clinics and animal hospitals; Nanocyn, a hospital-grade disinfectant; Acuicyn, an antimicrobial prescription solution for the treatment of blepharitis and the daily hygiene of eyelids and lashes; MucoClyns for the use in emergencies and safe to use on mucous membranes, cuts, abrasions, burns, and body surfaces; Endocyn root canal irrigation solutions; and Sinudox for nasal irrigation. The company was formerly known as Oculus Innovative Sciences, Inc. and changed its name to Sonoma Pharmaceuticals, Inc. in December 2016. Sonoma Pharmaceuticals, Inc. was incorporated in 1999 and is based in Boulder, Colorado.

XTL Biopharmaceuticals NASDAQ:XTLB

XTL Biopharmaceuticals Ltd. engages in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases. Its pipeline includes hCDR1 and Erythropoietin. The company was founded on March 9, 1993 and is headquartered in Ramat Gan, Israel.